Source link : https://www.newshealth.biz/health-news/erenumab-offers-relief-for-moh-in-chronic-migraine/
TOPLINE: Erenumab, injected monthly at 140 mg, can effectively induce remission of nonopioid medication overuse headache (MOH) in patients with chronic migraine within 6 months. The treatment also significantly reduces the number of acute headache medication days (AHMDs). METHODOLOGY: Researchers conducted a phase 4, double-blind, parallel-group, randomized, placebo-controlled study at 67 centers across North America, […]
Author : News Health
Publish date : 2024-10-04 13:41:51
Copyright for syndicated content belongs to the linked Source.